Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: J Immunother. 2007 May-Jun;30(4):425–437. doi: 10.1097/CJI.0b013e31802fd8e2

FIGURE 4.

FIGURE 4

Summary of TH1 cytokine profiles of CD4+ helper cells activated by AdVhAFP-engineered DC versus DC transduced with AdVlacZ among HCC patients (B12, A3, B11, A4, B1, and B10). Patients are listed in order of increasing serum AFP level. Results are expressed as average spot counts. DC (AdVlacZ)+CD4 is AdVlacZ engineered DC+CD4+ T cells; DC (AdVhAFP)+CD4 is AdVhAFP-engineered DC+CD4+ T cells.